|
||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
J. Cell Biol.,
Volume 142, Number 6, September 21, 1998 1583-1593

* Eisai London Research Laboratories, Bernard Katz Building, University College London, London WC1E 6BT, United
Kingdom; Cytochrome c has been shown to play a role
in cell-free models of apoptosis. During NGF withdrawal-induced apoptosis of intact rat superior cervical
ganglion (SCG) neurons, we observe the redistribution of cytochrome c from the mitochondria to the cytoplasm. This redistribution is not inhibited by the
caspase inhibitor Z-Val-Ala-Asp-fluoromethylketone (ZVADfmk) but is blocked by either of the neuronal
survival agents 8-(4-chlorophenylthio)adenosine 3':5'-cyclic monophosphate (CPT-cAMP) or cycloheximide.
Moreover, microinjection of SCG neurons with antibody to cytochrome c blocks NGF withdrawal-induced
apoptosis. However, microinjection of SCG neurons
with cytochrome c does not alter the rate of apoptosis
in either the presence or absence of NGF. These data
suggest that cytochrome c is an intrinsic but not limiting
component of the neuronal apoptotic pathway.
Ontogeny Inc., Cambridge, Massachusetts 02138; and § SmithKline Beecham, New Frontiers Science Park, Harlow,
Essex CM19 5AW, United Kingdom
This article has been cited by other articles:
|
|